Integrated cardiac safety assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance
Autor principal: | |
---|---|
Otros Autores: | |
Formato: | Libro electrónico |
Idioma: | Inglés |
Publicado: |
Hoboken, N.J. :
John Wiley & Sons
c2009.
|
Materias: | |
Acceso en línea: | https://recursos.uloyola.es/login?url=https://accedys.uloyola.es:8443/accedix0/sitios/ebook.php?id=178306 |
Ver en Universidad Loyola - Universidad Loyola Granada: | https://colectivo.uloyola.es/Record/ELB178306 |
Solicitar por préstamo interbibliotecario:
Correo
Tabla de Contenidos:
- The importance of cardiac safety assessments
- The biological basis of adverse drug reactions
- Cardiac structure and function
- Cardiac pathophysiology and disease
- Drug discovery and drug design
- Nonclinical development
- The thorough QT/QTc trial
- General safety assessments
- Therapeutic use trials and meta-analyses
- Assessment methodologies in nonexperimental postmarketing surveillance
- Postmarketing proarrhythmic cardiac safety assessments
- Generalized cardiac safety
- Medication errors, adherence, and concordance
- Future directions in drug safety.